Transition Therapeutics Inc. (TTHI) was a big mover last session, as its shares rose nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend of the company since April 9, as the stock is now down over 31%.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Transition Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. (ANIP), ZIOPHARM Oncology, Inc. (ZIOP) and Alexion Pharmaceuticals, Inc. (ALXN). While ANI Pharmaceuticals and ZIOPHARM Oncology sport a Zacks Rank #1 (Strong Buy), ALexion carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
TRANSITION THERAPEUTICS ORD (TTHI): Free Stock Analysis Report
ZIOPHARM ONCOLOGY INC (ZIOP): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies